The global mouth ulcers drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). There are several pivotal factors that are driving the market growth including high tobacco consumption and the increasing unhealthy dietary habits across the globe. Tobacco consumption is quite high as globally around 1.3 billion people were consuming tobacco in 2020 according to the World Health Organization. Moreover, there are studies that indicate that quitting smoking has a few side effects, one among which is the occurrence of mouth ulcers and cold symptoms for up to two weeks. Therefore, along with the high population base of smokers, if more people will quit smoking, there are chances of occurrence of mouth ulcers as a temporary side effect. To treat this, people will opt for various remedies including mouth ulcers drugs which will augment the global mouth ulcer drugs market.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/mouth-ulcers-drugs-market
Moreover, the easy availability of these drugs as over-the-counter (OTC) medicines is further likely to provide a major boost to the overall market growth. Among the range of drug classes available for mouth ulcer treatment, the antimicrobial drug class, as well as analgesic drug class, are the prominent categories that support the market growth. Hence, the companies are continuously launching new innovative products, with new marketing strategies to gain the available market share. For instance, in May 2020, US WorldMeds, LLC launched GELX ORAL GEL, a Zinc-Taurine bioactive barrier therapy for the treatment of oral pain associated with Oral Mucositis (OM).
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Drug Class
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: GlaxoSmithKline plc, and Celgene Corp., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Mouth Ulcers Drugs Market Report by Segment
By Drug Class
- Antimicrobial
- Antihistamine
- Analgesics
- Corticosteroids
- Others
By Application
- Oral Lichen Planus
- Aphthous Stomatitis
- Others
A full report of Mouth Ulcers Drugs Market is available at: https://www.omrglobal.com/industry-reports/mouth-ulcers-drugs-market
Mouth Ulcers Drugs Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- GlaxoSmithKline plc
- Celgene Corp.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
